Please login to the form below
chronic lung disease
This page shows the latest chronic lung disease news and features for those working in and with pharma, biotech and healthcare.
Roche’s flu pill Xofluza gains EU approval
This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
Latest news
-
Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO
On Wednesday, the European Commission granted Moderna’s COVID-19 vaccine, initially called mRNA-1273, a conditional marketing authorisation to prevent the disease in people aged 18 years and older. ... The trial also showed a 90.9% efficacy rate in
-
Moderna wins EU authorisation for COVID-19 vaccine
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
-
EMA recommends authorisation of Moderna’s COVID-19 vaccine
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
-
Roche’s flu pill Xofluza moves closer towards EU approval
This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
-
Roche scores another FDA approval for Xofluza
It can now add that it is the first and only antiviral medicine indicated for high-risk patients, such as those who have conditions including asthma, chronic lung disease, diabetes, heart ... Levi Garraway. “People with chronic conditions such as asthma
Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO
Moderna wins EU authorisation for COVID-19 vaccine
EMA recommends authorisation of Moderna’s COVID-19 vaccine
Roche’s flu pill Xofluza moves closer towards EU approval
More from news
Approximately 1 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
October 2020: diversity and inclusion in clinical trials round-up
People with chronic conditions such as diabetes, lung disease, and heart disease, and those of advanced age, had a poorer prognosis once infected with COVID-19. ... In the U.S., fewer healthcare providers have training, knowledge, and expertise in
October 2020: diversity and inclusion in clinical trials round-up
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Associate Account Director
-
Competitive Salary
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
-
Senior Account Executive
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
-
Account Manager
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Senior Medical Writer
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Medical Editor
-
Competitive Salary
- Merck & Co reveals plans for women’s health spinoff Organon
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- bluebird bio aiming to separate business units by year-end
- FDA accepts BMS’ investigational cardiovascular drug mavacamten for review
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- Clark Health promotes Siân Hurst to managing director role
- ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Merck & Co reveals plans for women’s health spinoff Organon
- Virtual agency The Difference Collective makes new hires to senior team
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- The impact of cancer on mental health during COVID-19
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
